Elevance Health Inc (ELV) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Elevance Health Inc (ELV) has a cash flow conversion efficiency ratio of 0.002x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($84.00 Million) by net assets ($44.03 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Elevance Health Inc - Cash Flow Conversion Efficiency Trend (2000–2025)
This chart illustrates how Elevance Health Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Elevance Health Inc for a breakdown of total debt and financial obligations.
Elevance Health Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Elevance Health Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ENGIE ADR/1 EO 1
F:GZFB
|
N/A |
|
Republic Services Inc
NYSE:RSG
|
0.082x |
|
Barrick Gold Corp
TO:ABX
|
0.080x |
|
Truist Financial Corp
NYSE:TFC
|
0.023x |
|
Bajaj Finance Limited
NSE:BAJFINANCE
|
-0.280x |
|
Baker Hughes Co
NASDAQ:BKR
|
0.087x |
|
Rheinmetall AG
F:RHM
|
0.015x |
|
Apollo Global Management LLC Class A
NYSE:APO
|
0.066x |
Annual Cash Flow Conversion Efficiency for Elevance Health Inc (2000–2025)
The table below shows the annual cash flow conversion efficiency of Elevance Health Inc from 2000 to 2025. For the full company profile with market capitalisation and key ratios, see Elevance Health Inc market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $44.03 Billion | $4.29 Billion | 0.097x | -30.50% |
| 2024-12-31 | $41.43 Billion | $5.81 Billion | 0.140x | -31.46% |
| 2023-12-31 | $39.41 Billion | $8.06 Billion | 0.205x | -11.51% |
| 2022-12-31 | $36.33 Billion | $8.40 Billion | 0.231x | -0.14% |
| 2021-12-31 | $36.13 Billion | $8.36 Billion | 0.232x | -28.09% |
| 2020-12-31 | $33.20 Billion | $10.69 Billion | 0.322x | +68.53% |
| 2019-12-31 | $31.73 Billion | $6.06 Billion | 0.191x | +42.47% |
| 2018-12-31 | $28.54 Billion | $3.83 Billion | 0.134x | -15.08% |
| 2017-12-31 | $26.50 Billion | $4.18 Billion | 0.158x | +23.68% |
| 2016-12-31 | $25.10 Billion | $3.20 Billion | 0.128x | -28.52% |
| 2015-12-31 | $23.04 Billion | $4.12 Billion | 0.179x | +28.56% |
| 2014-12-31 | $24.25 Billion | $3.37 Billion | 0.139x | +12.72% |
| 2013-12-31 | $24.77 Billion | $3.05 Billion | 0.123x | +6.89% |
| 2012-12-31 | $23.80 Billion | $2.74 Billion | 0.115x | -20.42% |
| 2011-12-31 | $23.29 Billion | $3.37 Billion | 0.145x | +143.55% |
| 2010-12-31 | $23.81 Billion | $1.42 Billion | 0.059x | -51.32% |
| 2009-12-31 | $24.86 Billion | $3.04 Billion | 0.122x | +3.32% |
| 2008-12-31 | $21.43 Billion | $2.54 Billion | 0.118x | -37.40% |
| 2007-12-31 | $22.99 Billion | $4.34 Billion | 0.189x | +14.84% |
| 2006-12-31 | $24.58 Billion | $4.04 Billion | 0.165x | +26.29% |
| 2005-12-31 | $24.99 Billion | $3.26 Billion | 0.130x | +94.57% |
| 2004-12-31 | $19.46 Billion | $1.30 Billion | 0.067x | -64.86% |
| 2003-12-31 | $6.00 Billion | $1.14 Billion | 0.191x | +3.11% |
| 2002-12-31 | $5.36 Billion | $991.10 Million | 0.185x | -41.84% |
| 2001-12-31 | $2.06 Billion | $654.60 Million | 0.318x | -10.88% |
| 2000-12-31 | $1.92 Billion | $684.50 Million | 0.357x | -- |
About Elevance Health Inc
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad… Read more